You are here

Cardinal to buy private generic drug distributor for US$1.12 billion

[BENGALURU] Cardinal Health Inc said it would buy privately held drug distributor Harvard Drug Group for US$1.12 billion.

Cardinal said it expects the deal to add more than 15 US cents per share to adjusted earnings from continuing operations in 2016 and 17 US cents per share in 2017.


Market voices on:

Powered by GET.comGetCom